AzTrials
AzTrials

ACL InjuryNCT04901559

Subjective Outcomes After ACL Reconstruction With BQT Autograft

An observational study of ACL Injury and Knee Injuries, run by Region Zealand.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of the study is to compare short-term patient reported outcome measures (PROM) of Bone-Quadriceps-Tendon (BQT) autograft with Semitendinosus-Gracilis (STG) and Bone-Patellar-Tendon-Bone (BPTB) autografts following Anterior Cruciate Ligament Reconstruction (ACLR). Read more about this study

Who is it for?
Any age
Conditions the study is for
ACL Injury, Knee Injuries
What is being tested?
Graft type at ACLR
Type of treatment
Surgery or procedure
How many people
30,000 participants
Where
No sites listed yet
Study dates
1 Jan 2005to 31 Dec 2018
How long will I take part?
1 Year
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • Child, Adult, Older adult

Study population: Patients from the nationwide Danish Knee Ligament Reconstruction Register (DKLR) recruited from both private and public clinics from January 1st 2005 through December 31st 2018.

Who may be able to join

  • -

Who cannot join

  • Revision ACL Surgery
  • Multiligament surgery
  • Nonresponders in PROM at preoperative baseline or one-year follow-up

About this study

The purpose of the study is to compare short-term patient reported outcome measures (PROM) of Bone-Quadriceps-Tendon (BQT) autograft with Semitendinosus-Gracilis (STG) and Bone-Patellar-Tendon-Bone (BPTB) autografts following Anterior Cruciate Ligament Reconstruction (ACLR).

The PROM used are Knee Injury and Osteoarthrithis Outcome Score (KOOS) and Tegner. Difference in change in KOOS, KOOS subscales and Tegner from preoperative baseline to one-year follow-up and absolute KOOS, KOOS subscales and Tegner at one-year follow-up were evaluated. All of which were BQT compared to STG and BPTB, respectively. The primary outcome is change in KOOS from preoperative baselinge to one-year follow-up. Other outcomes are secondary.

The hypothesis was that patients receiving the BQT autograft show similar results in KOOS, KOOS subscales and Tegner as patients receiving STG or BPTB autografts.

Being tested
Graft type at ACLR
Medical subject headings
Anterior Cruciate Ligament Injuries, Knee Injuries

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Graft type at ACLRProcedure or surgery

    The choice of graft at primary ACL Reconstruction

Study groups in NCT04901559
Study groupRoleWhat they receive
BQTPatients treated with the Bone Quadriceps Tendon (BQT) autograft
Receives: Procedure: Graft type at ACLR
STGPatients treated with the Semitendinosus-Gracilis (STG) autograft
Receives: Procedure: Graft type at ACLR
BPTBPatients treated with the Bone-Patellar Tendon-Bone (BPTB) autograft
Receives: Procedure: Graft type at ACLR

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Knee Injury and Osteoarthritis Outcome Score from preoperative baseline to one-year follow-up

    BQT compared to STG and BPTB, respectively

    Measured: 1 year

Secondary outcomes (12)
  1. Change in Knee Injury and Osteoarthritis Outcome Score subscale Pain from preoperative baseline to one-year follow-up

    BQT compared to STG and BPTB, respectively

    Measured: 1 year

  2. Change in Knee Injury and Osteoarthritis Outcome Score subscale Symptoms from preoperative baseline to one-year follow-up

    BQT compared to STG and BPTB, respectively

    Measured: 1 year

  3. Change in Knee Injury and Osteoarthritis Outcome Score subscale Activities of Daily Living (ADL) from preoperative baseline to one-year follow-up

    BQT compared to STG and BPTB, respectively

    Measured: 1 year

  4. Change in Knee Injury and Osteoarthritis Outcome Score subscale Sports/Recreation from preoperative baseline to one-year follow-up

    BQT compared to STG and BPTB, respectively

    Measured: 1 year

  5. Change in Knee Injury and Osteoarthritis Outcome Score subscale Quality of Life (QoL) from preoperative baseline to one-year follow-up

    BQT compared to STG and BPTB, respectively

    Measured: 1 year

  6. Change in Tegner activity score from preoperative baseline to one-year follow-up

    BQT compared to STG and BPTB, respectively

    Measured: 1 year

  7. Absolute results of Knee Injury and Osteoarthritis Outcome Score subscale Pain at one-year follow-up

    BQT compared to STG and BPTB, respectively

    Measured: 1 year

  8. Absolute results of Knee Injury and Osteoarthritis Outcome Score subscale Symptoms at one-year follow-up

    BQT compared to STG and BPTB, respectively

    Measured: 1 year

  9. Absolute results of Knee Injury and Osteoarthritis Outcome Score subscale Activities of Daily Living (ADL) at one-year follow-up

    BQT compared to STG and BPTB, respectively

    Measured: 1 year

  10. Absolute results of Knee Injury and Osteoarthritis Outcome Score subscale Sports/Recreation at one-year follow-up

    BQT compared to STG and BPTB, respectively

    Measured: 1 year

  11. Absolute results of Knee Injury and Osteoarthritis Outcome Score subscale Quality of Life (QoL) at one-year follow-up

    BQT compared to STG and BPTB, respectively

    Measured: 1 year

  12. Absolute results of Tegner activity score at one-year follow-up

    BQT compared to STG and BPTB, respectively

    Measured: 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 May 2021
  2. Study start1 Jan 2005
  3. Primary completion31 Dec 2018
  4. Study completion31 Dec 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
30,000 participants (actual)
Target duration
1 Year
IDs, dates and publications
ClinicalTrials.gov ID
NCT04901559
Sponsor's protocol ID
BQT-1
Status last verified
May 2021
First submitted
12 May 2021
Last updated
25 May 2021
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of ACL Injury and Knee Injuries, run by Region Zealand.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 25 May 2021. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Knee Injury and Osteoarthritis Outcome Score from preoperative baseline to one-year follow-up (time frame: 1 year). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 May 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in